# Neuromodulation During the Prodrome to Prevent Disabling Migraine Attacks in Youth

> clinical trial · VERIFIED · 2026-08-19

Status: NOT_YET_RECRUITING · Sponsor: University of Calgary · Condition: Migraine

- Company: University of Calgary
- Sector: neurotech
- Primary source: https://clinicaltrials.gov/study/NCT07772427

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.